243 related articles for article (PubMed ID: 33419357)
1. Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy.
Ravegnini G; Fosso B; Saverio VD; Sammarini G; Zanotti F; Rossi G; Ricci M; D'Amico F; Valori G; Ioli A; Turroni S; Brigidi P; Hrelia P; Angelini S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419357
[TBL] [Abstract][Full Text] [Related]
2. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.
Garcia-Pelaez J; Barbosa-Matos R; Gullo I; Carneiro F; Oliveira C
Mol Oncol; 2021 Nov; 15(11):2841-2867. PubMed ID: 33724653
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Profiling of Gastric Signet Ring Cell Carcinoma Tissues Reveals Characteristic Changes of the Complement Cascade Pathway.
Fan Y; Bai B; Liang Y; Ren Y; Liu Y; Zhou F; Lou X; Zi J; Hou G; Chen F; Zhao Q; Liu S
Mol Cell Proteomics; 2021; 20():100068. PubMed ID: 33676000
[TBL] [Abstract][Full Text] [Related]
5. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
[TBL] [Abstract][Full Text] [Related]
6. Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma.
Moon KC; Cho SY; Lee HS; Jeon YK; Chung JH; Jung KC; Chung DH
Arch Pathol Lab Med; 2006 Sep; 130(9):1320-5. PubMed ID: 16948518
[TBL] [Abstract][Full Text] [Related]
7. Differential microRNA expression in signet-ring cell carcinoma compared with tubular adenocarcinoma of human gastric cancer.
Li FQ; Xu B; Wu YJ; Yang ZL; Qian JJ
Genet Mol Res; 2015 Jan; 14(1):739-47. PubMed ID: 25730011
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
Murakami H; Nakanishi H; Tanaka H; Ito S; Misawa K; Ito Y; Ikehara Y; Kondo E; Kodera Y
Gastric Cancer; 2013 Jan; 16(1):74-83. PubMed ID: 22450770
[TBL] [Abstract][Full Text] [Related]
9. Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features.
Zhao W; Jia Y; Sun G; Yang H; Liu L; Qu X; Ding J; Yu H; Xu B; Zhao S; Xing L; Chai J
Nat Commun; 2023 May; 14(1):2985. PubMed ID: 37225691
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.
Bozkaya Y; Erdem GU; Ozdemir NY; Demirci NS; Hocazade C; Yazıcı O; Zengin N
Curr Med Res Opin; 2017 Jan; 33(1):109-116. PubMed ID: 27646639
[TBL] [Abstract][Full Text] [Related]
11. Primary signet-ring cell carcinoma of the lung: histochemical and immunohistochemical characterization.
Hayashi H; Kitamura H; Nakatani Y; Inayama Y; Ito T; Kitamura H
Hum Pathol; 1999 Apr; 30(4):378-83. PubMed ID: 10208457
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics and outcomes in stage I-III mucinous gastric adenocarcinoma: a retrospective study at a single medical center.
Hsu JT; Wang CW; Le PH; Wu RC; Chen TH; Chiang KC; Lin CJ; Yeh TS
World J Surg Oncol; 2016 Apr; 14():123. PubMed ID: 27112436
[TBL] [Abstract][Full Text] [Related]
13. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.
Togasaki K; Sugimoto S; Ohta Y; Nanki K; Matano M; Takahashi S; Fujii M; Kanai T; Sato T
Gastroenterology; 2021 Feb; 160(3):823-830. PubMed ID: 33217450
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer.
Lim JY; Yoon SO; Seol SY; Hong SW; Kim JW; Choi SH; Cho JY
World J Gastroenterol; 2012 Aug; 18(30):4037-43. PubMed ID: 22912555
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
[TBL] [Abstract][Full Text] [Related]
16. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
17. Prediction of lymph node metastasis in early gastric signet-ring cell carcinoma: A real-world retrospective cohort study.
Yang JJ; Wang XY; Ma R; Chen MH; Zhang GX; Li X
World J Gastroenterol; 2023 Jun; 29(24):3807-3824. PubMed ID: 37426318
[TBL] [Abstract][Full Text] [Related]
18. Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China.
Yu G; Hu N; Wang L; Wang C; Han XY; Humphry M; Ravel J; Abnet CC; Taylor PR; Goldstein AM
Int J Cancer; 2017 Jul; 141(1):45-51. PubMed ID: 28319273
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
